In a longer and larger observational study of German patients, followed up for 1–31 years, mortality was 43% among the seven untreated homozygotes compared with 21% in the 14 who were treated with Lp ...

HDL was reduced from 1.0 ± 0.2 mmol/L pre- to 0.5 ± 0.1 mmol/L post-apheresis (p = 0.03). It increased following apheresis and then remained constant throughout the evolocumab treatment. Lp(a) ...

Apo B tests are blood tests that measure the concentration of Apolipoprotein B in the blood, which carries cholesterol that can cause a number of blood vessel and heart conditions.

Subhash Banerjee, MD (VA North Texas Health Care System & UT Southwestern Medical Center, Dallas), who presented the results of the PREMIER trial in a featured clinical research session at the annual ...

Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — LDL apheresis was safe and was linked to a trend toward early coronary atheroma regression in ...

The dosing recommendation was based on data from a double-blind, placebo-controlled study conducted in 62 patients with HeFH undergoing LDL apheresis. The labeling for Praluent (alirocumab; Sanofi and ...

Evinacumab (Regeneron), a fully human monoclonal antibody inhibitor of angiopoietin-like protein 3 (ANGPTL3), substantially lowers LDL cholesterol in patients with homozygous familial ...

Heart attack despite a healthy diet? Stroke without high blood pressure? The reason might lie in the blood—and few people know about it. Lipoprotein(a) is a value that is genetically determined and ...

Dennis R. Leahy, MD, shares his POV on the value of making Lp(a) testing universal, not only to inform patients and their clinicians of the high CV risks, but to make way for potential treatments.

SAN DIEGO, CA. - September 11, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a developer of dialysis-like therapies to address cardiovascular disease and ...

An acute reduction in total cholesterol of ≥65%, or in LDL cholesterol of ≥70%, during each procedure; An interval mean total cholesterol of <7 mmol/l or LDL cholesterol <6.5 mmol/l (or decreases of ...